Identifying Exercise Interventions That May Slow the Progression of Cognitive Decline in Older Adults With Mild

Kerstin Castro1,2, Jo Ann M Bamdas3, Maria D Ortega4

  • 1Medical School, Edward Via College of Osteopathic Medicine, Spartanburg, USA.

Cureus
|April 21, 2025
PubMed

Insights

Regular exercise, including resistance training and combined modalities, can significantly slow cognitive decline in older adults with mild cognitive impairment (MCI). This approach offers a promising alternative to pharmacological interventions for improving cognitive function.

Area of Science:

  • Gerontology and Cognitive Neuroscience
  • Exercise Physiology and Public Health

Background:

  • Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia, characterized by cognitive deficits not significantly impacting daily life.
  • Evidence suggests exercise interventions can mitigate cognitive decline, yet research in the U.S. is limited, potentially due to a focus on pharmaceutical treatments.
  • Identifying effective exercise strategies is crucial for managing MCI in aging populations.

Purpose of the Study:

  • To conduct a scoping review of randomized controlled trials (RCTs) investigating exercise interventions for older adults with MCI.
  • To identify specific exercise types and cognitive measures associated with slowing cognitive progression in this demographic.
  • To evaluate the efficacy of different exercise modalities in improving cognitive function among older adults.

Main Methods:

  • A scoping review was performed following PRISMA-ScR guidelines, searching five major databases (PubMed, GALE, Wiley, EBSCOHost, OVID).
  • Searches focused on RCTs examining exercise interventions and cognitive decline in older adults with MCI, conducted between September 2022 and February 2023.
  • Ten international RCTs involving 1,075 participants (668 in intervention/control groups) were analyzed.

Main Results:

  • Combined exercise modalities demonstrated more significant benefits for global cognitive functioning compared to control groups.
  • Resistance training emerged as a particularly promising intervention for older adults experiencing MCI.
  • The review identified international studies, highlighting a need for more U.S.-based research.

Conclusions:

  • Exercise interventions, particularly combined modalities and resistance training, are effective in slowing cognitive decline in older adults with MCI.
  • Non-pharmacological approaches like exercise should be considered for managing MCI.
  • Further research, especially within the U.S., is warranted to explore exercise's role in cognitive health for aging populations.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
23
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
85
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
317
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148